CYRANO THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
Study of CYR-064 Versus Placebo in Patients.
Phase 2
Active, not recruiting
- Conditions
- Hyposmia
- Interventions
- Combination Product: CYR-064
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Cyrano Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06019000
- Locations
- 🇺🇸
Colorado ENT & Allergy, Colorado Springs, Colorado, United States
🇺🇸ENTAAFL, Port Saint Lucie, Florida, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath